Updated 08:05 GMT, 20 Nov 2026 SPX 7,175.83 -2.02% NDX 26,517.05 -2.21% VIX 28.44 +15.80% GOLD 3,574.90 -3.00% CL 82.63 -0.70% BTC 61,735.58 -0.27%
NAS100 26,517 −2.21% S&P 7,176 −2.02% GOLD $3,575 −3.00% BTC $61,736 −0.27% VIX 28.44 +15.80% latest tape · as of 08:05 UTC
The Screen · Energy

Sabine Royalty Trust logoSabine Royalty Trust

SBR · the NYSE · USD · Market cap $944M

PASS · Titan Ethical
61.49 USD

Price as of 19 Nov 2026Daily close, not a live quote

Screened 2026-11-19 · the tape above runs as of 08:05 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price61.49 USD at the 19 Nov 2026 close
  • Fair valueUnder review: our model has no usable estimate for it yet.
  • Our regime readMarkdown, as of 16 Nov 2026
  • Ethical screenPasses
  • Last reviewed19 Nov 2026 (1 day ago)
  • Release timesRelease and earnings times on your chart: Event Guard Mentor

A summary of the dated readings below, not a live quote and not advice.

PRICE · ONE YEAR

Our fair-value range: range not available (screen dated 2026-11-19).

Current read
Markdown ?
Screened · screened 2026-11-19
  • Trend Markdown
  • Insiders no filings inside 60 days, left as found
  • Positioning no disclosures inside 60 days, left as found
  • Options no verdict drawn today, left as found
  • Ethical passes the values gate
Price61.49 USD
Fair valueUnder review
Our investment reviews on this name
2026-11-04Read Markdown68.64-10.4% to today ✓Accumulation gives way to Markdown first Markdown read since October
2026-10-21Read Accumulation71.94-14.5% to today Markdown gives way to Accumulation
2026-10-02Read Markdown72.48-15.2% to today ✓Accumulation gives way to Markdown first Markdown read since August
2026-09-12Read Accumulation74.71-17.7% to today Markdown gives way to Accumulation first Accumulation read since July

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its markdown label.

Sabine Royalty Trust holds its Markdown at $61.49. Consolidating, no directional conviction, held for 220 days.

As held on the ledger · 2026-11-19
PhaseMarkdown · caution
Quantitative stateConsolidating, no directional conviction, held for 220 days
Price at the screen$61.49
Valuation13.21 trailing · N/A forward price to earnings
Values screenPASS
Beta0.30
The Workings

Five Screens: SBR's Results

PASS. All five recorded results clear their limits.

TestFigureLimitStatus
Business activity Permissible Permissible core business Pass
Debt load 0.00% Below 33% Pass
Interest-bearing cash 0.67% Below 33% Pass
Receivables 0.00% Below 49% Pass
Revenue purity 0.61% Below 5% Pass

Definitions, sources and threshold rules: ticker values-screen methodology.

The Ethical Read

Why It Clears, in Plain English

Sabine Royalty Trust clears all five screens. Its business is in a permissible area, its debt is near-nil, and almost none of its income is interest, so it passes.

Read as at 2026-11-19. It updates when the underlying figures move, and past reads are kept below.

Follow this verdict

Get an email when SBR's ethical verdict changes

Today SBR passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.

Free, no account needed. Every email has a link to stop.

What the Numbers Say It Is Worth

The Fair Value Range

Fair value under review. Our model has no usable estimate for it yet. We show no fair value, margin of safety or value read built on it until the review clears.

Model construction and limits: fair-value methodology.

Price History & Projections

Where our models see it going: no fair-value estimate yet, range not available, dated to the 2026-11-19 screen.

How our estimate and third-party targets differ.

The Business, in Plain Words
The fundamentals · plain-English read
Trailing P/E13.2xreasonably valued
EPS, trailing4.90
Revenue growth+16.5%steady growth
Profit margin94.7%highly profitable on every dollar of sales
Return on equity914.2%an exceptional return on shareholder capital
Dividend yield7.05%
Current ratio31.55comfortably covers its short-term bills
Beta0.30barely tracks the market's swings
Short interest, float0.00%
52-week range64.65 - 79.86
Market cap$944M

SBR-specific watchpoints · The things to watch: it's a small-cap, so the share price can swing harder than the market.

Metric definitions and interpretation rules: ticker-page methodology.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-11-17 Markdown $64.28 -2.4% Entry 16

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 2.4% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading oversold. Over the past year the shares are up 27%. Our forward projection puts the odds of a 10% gain over the next month near 16%.

2026-11-06 Markdown $65.86 -2.6% Entry 15

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 2.6% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 0% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 27%. Our forward projection puts the odds of a 10% gain over the next month near 16%. It reported earnings in this window, a natural checkpoint for the thesis.

2026-11-05 Markdown $67.62 -1.5% Entry 14

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 1.5% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 0% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 27%. Our forward projection puts the odds of a 10% gain over the next month near 16%. It reported earnings in this window, a natural checkpoint for the thesis.

2026-11-04 Markdown · changed $68.64 -0.9% Entry 13

The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.9% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 0% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 27%. Our forward projection puts the odds of a 10% gain over the next month near 16%. It reported earnings in this window, a natural checkpoint for the thesis.

2026-11-03 Accumulation $69.28 -2.2% Entry 12

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 2.2% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 0% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 27%. Our forward projection puts the odds of a 10% gain over the next month near 16%. It reported earnings in this window, a natural checkpoint for the thesis.

2026-11-02 Accumulation $70.86 +0.0% Entry 11

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 0% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 27%. Our forward projection puts the odds of a 10% gain over the next month near 16%. It reported earnings in this window, a natural checkpoint for the thesis.

2026-11-01 Accumulation $70.86 +0.0% Entry 10

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 0% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 27%. Our forward projection puts the odds of a 10% gain over the next month near 16%. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-31 Accumulation $70.86 -0.6% Entry 9

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.6% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 0% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 27%. Our forward projection puts the odds of a 10% gain over the next month near 16%. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-30 Accumulation $71.28 -0.9% Entry 8

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.9% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 0% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 27%. Our forward projection puts the odds of a 10% gain over the next month near 16%. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-21 Accumulation · changed $71.94 -0.7% Entry 7

The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.7% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 0% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 27%. Our forward projection puts the odds of a 10% gain over the next month near 16%.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

Latest News · What the Market Is Reading on SBR

Headlines from third-party outlets, linked for reference: not our reporting, not advice.

Related Securities · Others in SBR's Space

Screened names in the same industry · explore each on its own page.

The Political Ledger · Congressional Disclosures
Disclosures naming SBR
DatePoliticianPartyTypeAmount
2026-07-24 John Fetterman Democrat sell 1K–15K
What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $71.90 -14.7% $0.36 $859 -14.1%
2 months $72.71 -15.6% $0.72 $854 -14.6%
3 months $71.58 -14.3% $1.05 $872 -12.8%
6 months $74.31 -17.4% $2.60 $861 -13.9%
1 year $73.50 -16.5% $4.51 $896 -10.4%
2 years $54.03 +13.6% $9.79 $1,317 +31.7%
3 years $48.53 +26.4% $16.07 $1,595 +59.5%
5 years $27.18 +125.8% $30.28 $3,372 +237.2%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever SBR does next, these words stay.

Sabine Royalty Trust · SBR · Markdown · $61.49
Recorded 2026-11-19 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.